Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Development, validation, and initial results of the Angioedema Activity Score.

Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, Metz M, Staubach P, Maurer M.

Allergy. 2013 Sep;68(9):1185-92. doi: 10.1111/all.12209. Epub 2013 Aug 6.

PMID:
23919330
2.

Development and construct validation of the angioedema quality of life questionnaire.

Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, Metz M, Staubach P, Maurer M.

Allergy. 2012 Oct;67(10):1289-98. doi: 10.1111/all.12007. Epub 2012 Aug 23.

PMID:
22913638
3.

Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.

Weller K, Groffik A, Church MK, Hawro T, Krause K, Metz M, Martus P, Casale TB, Staubach P, Maurer M.

J Allergy Clin Immunol. 2014 May;133(5):1365-72, 1372.e1-6. doi: 10.1016/j.jaci.2013.12.1076. Epub 2014 Feb 9.

PMID:
24522090
4.

Outcomes and patient-based hearing status in conductive hearing loss.

Stewart MG.

Laryngoscope. 2001 Nov;111(11 Pt 2 Suppl 98):1-21. Review.

PMID:
11802001
5.
6.

Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients.

Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R; Impact of Dry Eye on Everyday Life (IDEEL) Study Group.

Health Qual Life Outcomes. 2011 Dec 8;9:111. doi: 10.1186/1477-7525-9-111.

7.

The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument.

Rapp SR, Feldman SR, Graham G, Fleischer AB, Brenes G, Dailey M.

Am J Clin Dermatol. 2006;7(3):185-92.

PMID:
16734506
8.

A valid and reliable measure of constipation-related quality of life.

Wang JY, Hart SL, Lee J, Berian JR, McCrea GL, Varma MG.

Dis Colon Rectum. 2009 Aug;52(8):1434-42. doi: 10.1007/DCR.0b013e3181a51196.

PMID:
19617757
9.

Development and validation of the cough severity index: a severity index for chronic cough related to the upper airway.

Shembel AC, Rosen CA, Zullo TG, Gartner-Schmidt JL.

Laryngoscope. 2013 Aug;123(8):1931-6. doi: 10.1002/lary.23916. Epub 2013 Jun 4.

PMID:
23737389
10.

Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).

Brod M, Hammer M, Christensen T, Lessard S, Bushnell DM.

Health Qual Life Outcomes. 2009 Sep 9;7:83. doi: 10.1186/1477-7525-7-83.

11.

The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33).

Mohtadi NG, Griffin DR, Pedersen ME, Chan D, Safran MR, Parsons N, Sekiya JK, Kelly BT, Werle JR, Leunig M, McCarthy JC, Martin HD, Byrd JW, Philippon MJ, Martin RL, Guanche CA, Clohisy JC, Sampson TG, Kocher MS, Larson CM; Multicenter Arthroscopy of the Hip Outcomes Research Network.

Arthroscopy. 2012 May;28(5):595-605; quiz 606-10.e1. doi: 10.1016/j.arthro.2012.03.013.

PMID:
22542433
12.

Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.

Huxley P, Evans S, Madge S, Webber M, Burchardt T, McDaid D, Knapp M.

Health Technol Assess. 2012;16(1):iii-vii, ix-xii, -1-241. doi: 10.3310/hta16010.

13.

Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale.

Shaffer BT, Cohen MS, Bigelow DC, Ruckenstein MJ.

Laryngoscope. 2010 Aug;120(8):1646-54. doi: 10.1002/lary.20988.

PMID:
20641085
14.

A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).

Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ, Frech F, Van Assche D.

Br J Dermatol. 2004 Feb;150(2):274-83.

PMID:
14996098
15.

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.

Siebenhaar F, von Tschirnhaus E, Hartmann K, Rabenhorst A, Staubach P, Peveling-Oberhag A, Wagner N, Martus P, Carter MC, Metcalfe DD, Church MK, Maurer M, Weller K.

Allergy. 2016 Jun;71(6):869-77. doi: 10.1111/all.12842. Epub 2016 Feb 15.

PMID:
26797792
16.

An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation.

Sch√ľnemann HJ, Sperati F, Barba M, Santesso N, Melegari C, Akl EA, Guyatt G, Muti P.

Health Qual Life Outcomes. 2010 Mar 11;8:26. doi: 10.1186/1477-7525-8-26.

17.
18.

The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.

Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Dabbaghzade A, Tavakol Z, Afarideh M, Rezaei N.

Iran J Allergy Asthma Immunol. 2014 Aug;13(4):278-85.

19.

[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].

Zanello A, Weber Rouget B, Gex-Fabry M, Maercker A, Guimon J.

Encephale. 2006 Jan-Feb;32(1 Pt 1):45-59. French.

PMID:
16633290
20.

Initial validity and reliability of the Banff Patella Instability Instrument.

Hiemstra LA, Kerslake S, Lafave MR, Heard SM, Buchko GM, Mohtadi NG.

Am J Sports Med. 2013 Jul;41(7):1629-35. doi: 10.1177/0363546513487981. Epub 2013 May 6.

PMID:
23649006

Supplemental Content

Support Center